[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy. - Wikidata - wikimedia - TriplyDB

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.

http://www.wikidata.org/entity/Q45330298

about

Update on positron emission tomography for imaging of prostate cancer Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology Imaging metabolic heterogeneity in cancer PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Update on advances in molecular PET in urological oncology Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.Management of urological malignancies: Has positron emission tomography/computed tomography made a difference?Clinical Indications of C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse.Distribution Features of Skeletal Metastases: A Comparative Study between Pulmonary and Prostate Cancers.Functional imaging for prostate cancer: therapeutic implications.Molecular imaging of prostate cancer: PET radiotracers.Translational Molecular Imaging of Prostate Cancer.Management of metastatic castration-resistant prostate cancer: recent advances.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Choline PET/CT for imaging prostate cancer: an update.Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.Imaging and evaluation of patients with high-risk prostate cancer.Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.PET imaging for lymph node dissection in prostate cancer.Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer.A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer.(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate canc Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer.Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence.Comparison of distribution characteristics of metastatic bone lesions between breast and prostate carcinomas.When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer.Role of ¹⁸F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer.Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study.Current status of theranostics in prostate cancer.Antitumor T cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy.The use of PET/CT in prostate cancer.Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early ¹⁸F-FCH PET/CT?Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.2013: another good year for EJNMMI.Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment.

P2860

Q27026828-DA4094E5-B411-45C3-8EEB-D75E970A9ABF Q28071705-9446DBE0-BE4E-4AA5-A6D1-62D3D266B8C9 Q28076500-A76C5238-96E2-471D-B6DA-9142B7778404 Q31003607-25A8414C-0439-42EA-896A-F8F4FD9C7BED Q33625389-0DA938D6-D7D7-4150-819B-26AC01640C16 Q34748629-B6DFA864-E1CD-4275-92C5-5765D76EB742 Q34990800-A4CEEF6D-AB6A-4B36-BA8A-478937695D5A Q35849174-F4E68577-5570-4DC3-A548-F03EEDBDA123 Q35850043-3BA18D5B-BF8F-45AA-B4C5-C886FCABE578 Q36128629-F45412BA-076B-474B-85A2-999630821807 Q36129937-5989AA87-002F-4854-8710-890E434EB8B9 Q37244969-30F72057-FF8F-427E-9653-957C56DBFF66 Q38012528-943C77A3-BF3B-4A25-93AB-9CD173228DDE Q38098441-F8DC0471-49B9-41A0-9B45-DD01CD94EB1E Q38103180-54E8A135-D2D4-470F-B21A-B6947F7FF377 Q38212848-11A4C4EC-D9BF-4122-9143-576446D80258 Q38321182-A0D0DE6A-9025-449A-AD2B-5BFAFF3FE7EC Q38564109-E8BB3F29-587D-435B-91A2-A042F83EDF94 Q38611187-B7BB113A-F9C7-4A2F-A69A-CD676801E225 Q38766102-51069ECF-B71F-4265-BAAC-6DE2FA4FB3BE Q38983526-72642415-8C95-47BF-B19B-F49C4D9BF362 Q39690658-D53A76C0-7B79-429B-9AB4-008AD82AF028 Q40735810-87DFDD5D-995D-42A8-AB1F-D8E64F9147A3 Q41161118-874A3B40-5E9B-4139-B6C2-FA5FE8EE2069 Q41482900-ED172CF4-E242-479C-9FFF-B8DB598019E7 Q41563753-95C65676-EF5F-49D2-84EE-724E4D78C594 Q41827640-BC47540F-5800-4330-8761-0F07175E681D Q41903039-336F5AD2-2DCA-48E4-8B09-FB1DD9D9F3F5 Q42088489-9A8224B8-63C1-4ACF-B4BF-16527323FE37 Q45760116-AABB14F7-5780-4117-BA0C-8AEC762568ED Q45992756-83C24314-03F1-4AB6-9F65-7F71AE08EBCC Q47241139-C72B4926-2EC2-458F-B05F-B8CF99FEDF50 Q49546319-F91C891F-2F46-4ECF-A75D-3E4415DC9562 Q49919217-7DF4D55D-420B-4265-8498-58DA319B8A14 Q52983467-7B812DBF-ADAE-4E7B-AF0B-538B9FBA20BA Q52990619-5C799EEB-6FD0-426B-9951-33345728DD5D Q52991811-5EE7B9A7-0622-4B59-8FBE-5DE0A7B0DDEE Q53682227-01B9BEC2-000D-4A0A-8B24-4F8446FF88E3 Q54672079-E79FCDB5-8C4D-4957-9908-76D50B827DF2 Q55188040-3FA400B5-D1F3-48FE-9FC4-81C30A85F8F8

P2860

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.

http://www.wikidata.org/entity/Q45330298

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

[11C]Choline PET/CT detection ...... arison with bone scintigraphy.

@en

[11C]Choline PET/CT detection ...... arison with bone scintigraphy.

@nl

type

label

[11C]Choline PET/CT detection ...... arison with bone scintigraphy.

@en

[11C]Choline PET/CT detection ...... arison with bone scintigraphy.

@nl

prefLabel

[11C]Choline PET/CT detection ...... arison with bone scintigraphy.

@en

[11C]Choline PET/CT detection ...... arison with bone scintigraphy.

@nl

P1433

Q45330298-015CB13D-14C5-4E59-B365-ACFC0DD752AB

P1476

Q45330298-88DC3457-30B0-4DD4-A134-E0B5C920CFE4

P2093

Q45330298-0059037C-3C33-42FD-99AE-9648AF3D8CAA

Q45330298-2A4ACEB2-5903-4D12-B3F6-84B78CE38B9C

Q45330298-3807D369-5A92-4845-8A71-6EDA51BCCBC3

Q45330298-57536617-FA78-43DC-95CF-9EBDC730013E

Q45330298-9F4AEB3B-73E0-4177-B19B-8F6F7FDAF761

P2860

Q45330298-0DD1145F-13F1-4CE4-B11E-FE61CCB6855F

Q45330298-12AFCF29-877A-4864-A6A9-627E5481EC09

Q45330298-17490508-F710-450F-A3CF-0C3B6F57606C

Q45330298-23A572C0-BAD7-4AFB-9331-606540DED902

Q45330298-28EF711F-F211-4FB4-BA1D-36DE7E36A6B9

Q45330298-30B7D5C7-B7A3-40A7-BD17-40B52E2DC7BC

Q45330298-354EEA46-9BCD-4739-A5C2-F690D59CA6E2

Q45330298-48F2C5D0-7872-48D6-9F12-D7BB19663D81

Q45330298-57FE80B8-ABD5-4DF3-9E08-14F30C85F2C8

Q45330298-5B5412B1-DC2F-42A7-8DB7-1B4E844FBA4D

P2888

Q45330298-2C4729BC-584E-47D8-8330-F3B87B68D84D

P304

Q45330298-12807362-7BA7-482D-A4AB-46301E9FF8EA

P31

Q45330298-3C22B3EE-B29E-424F-91D8-DDC04FF6942F

P356

Q45330298-D44B6A89-8CAF-4732-BF99-0A52FAC61825

P433

Q45330298-84B2612A-2068-4D42-B9B8-6F41F215C66F

P478

Q45330298-D76FDDE5-A475-4456-A5EA-13E5DC4385AF

P50

Q45330298-07B3FDD7-69D5-45F4-AA10-FBE22C59F3F5

Q45330298-6B77C396-017D-42F6-B87C-C8F832A7D4C5

P577

Q45330298-09A4AFB7-5E96-4893-869D-856F796DC1CA

P6179

Q45330298-ECB67B7F-32E6-4639-8FFD-99A40C54FF26

P698

Q45330298-154FF5E6-8D42-4DF2-A440-F55B08DDF7DA

P921

Q45330298-250E3FE6-7F83-4BAB-B1E8-CB646DE325C9

P356

S00259-011-1920-Z

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

[11C]Choline PET/CT detection ...... arison with bone scintigraphy.

@en

P2093

Cristina Messa

http://www.w3.org/2001/XMLSchema#string

Elena Giulia Spinapolice

http://www.w3.org/2001/XMLSchema#string

Federico Fallanca

http://www.w3.org/2001/XMLSchema#string

Giampiero Giovacchini

http://www.w3.org/2001/XMLSchema#string

Luigi Gianolli

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

Baseline staging of newly diagnosed prostate cancer: a summary of the literature.

Positron emission tomography for prostate, bladder, and renal cancer.

Imaging prostate cancer: a multidisciplinary perspective.

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

Prostate cancer: role of SPECT and PET in imaging bone metastases.

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

P2888

s00259-011-1920-z

P304

13-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-011-1920-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Cinzia Crivellaro

P577

2011-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027634743

http://www.w3.org/2001/XMLSchema#string

P698

21932120

http://www.w3.org/2001/XMLSchema#string

P921